| 摘要 |
A formulation for use to treat a person who snores when he or she sleeps, the said formulation comprising an effective amount of yohimbine (3 alpha -15 alpha -20 beta -17 alpha -hydroxy yohimbine-16 alpha carboxylic acid methyl ester) and pharmaceutically tolerable forms thereof (for example, salts, esters and the like), in a pharmaceutically acceptable carrier.
|
